We may earn money or products from the companies mentioned in this post.
Educational information only. This article does not replace medical advice, diagnosis, or treatment.
Talk with your own clinician before you start, stop, or switch any method.
Quick answer: Pregnancy remains possible during perimenopause, even with skipped periods or hot flashes. Birth control choices depend on pregnancy-prevention goals, bleeding, health history, medicines, and preferences. Menopausal hormone therapy is not contraception. Ask for an individual plan before starting, switching, or stopping a method.
Cycles can run long, short, heavy, or light. Some months you skip a period and then it shows up again like nothing happened. A late period in your 40s tells you very little about whether you can get pregnant.
This guide compares the main options and explains what to discuss with your clinician. No single method or stopping rule fits everyone.
Why Contraception May Still Be Needed During Perimenopause
Fertility declines with age, but pregnancy can still occur after age 44. Natural menopause is identified after 12 consecutive months without a period when another cause does not explain it. Hormonal methods and procedures that stop bleeding can make that marker difficult to interpret.
You only know you have reached it by looking back.
Ovulation can still occur during irregular cycles. A skipped period does not establish that pregnancy is impossible.
Pregnancy later in life also tends to carry higher medical risks than it does earlier. Many clinicians bring up contraception with patients who figure they are “basically done” for that reason.
Irregular cycles make calendar-only predictions less dependable. Hot flashes and sleep changes do not establish that contraception is no longer needed.
If you want to avoid pregnancy, discuss a method that fits your current circumstances rather than relying on symptoms or a few missed periods.
Our perimenopause timing article covers how long this phase can last, and it makes a good first read if you are unsure where you are.
Choosing Around Pregnancy Prevention, Bleeding Patterns, Symptoms, and Preferences
Most people end up weighing four things.
Pregnancy prevention. Some methods depend on you remembering something every day or every time. Long-acting methods remove the daily task but still require attention to side effects and replacement or removal dates.
Bleeding. Some methods make periods lighter or stop them. Some make them more regular.
Others may cause spotting, heavier bleeding, or unpredictable bleeding.
Symptoms. You may also want help with heavy bleeding, cramps, or hot flashes. Approval depends on the exact product and condition; some symptom uses are off-label. Discuss the evidence and the need to investigate abnormal bleeding first.
Preferences and health history. Hormone-free, needle-free, reversible, permanent, or no daily task: these are all reasonable preferences. Cost, access, privacy, ease of removal, and future pregnancy goals also matter.
The Main Options
Combined Pill, Patch, and Ring
These contain estrogen and a progestin. All three are approved to prevent pregnancy. Many people also notice more predictable bleeding.
Some symptom uses are off-label, meaning they fall outside the particular FDA-approved indication. Do not assume every bleeding-related use is off-label: Natazia, for example, has a heavy-menstrual-bleeding indication for eligible women without organic pathology who choose oral contraception. This example is not a recommendation for that product.
The cautions matter. The FDA labels for these products carry a boxed warning about cigarette smoking and serious heart and blood vessel problems, especially for women over 35.
Estrogen-containing methods also carry labeled warnings about blood clots, stroke, and heart attack.
The risk picture shifts with age, smoking, blood pressure, and migraine with aura.
CDC eligibility guidance distinguishes smoking intensity at age 35 or older: combined hormonal contraception is category 3 with fewer than 15 cigarettes daily and category 4 with 15 or more. Category 3 means risks usually outweigh benefits; category 4 means an unacceptable health risk. A clinician must review the complete eligibility picture.
Progestin-Only Methods
This group includes the progestin-only pill, implant, and injection; hormonal IUDs also contain a progestin. They may be options when estrogen is unsuitable, but they have their own contraindications and interactions. They are not automatically suitable for everyone who cannot use estrogen.
The progestin-only pill has to be taken at a steady time each day. The timing window is tighter for some types than others.
Bleeding often becomes irregular.
The implant is a small rod placed under the skin of the upper arm. The current US Nexplanon label allows pregnancy prevention for up to five years, updated in January 2026. Older resources may still list three years. Confirm the removal or replacement date with the clinician who manages your implant.
It ranks among the most effective methods, though irregular bleeding is common and can wear on you.
The DMPA injection is generally given every three months. CDC also supports clinician-prescribed self-administration of the subcutaneous formulation as an additional option; that route of administration is off-label and requires appropriate guidance. Do not assume all injectable formulations can be used this way.
The Depo-Provera CI label carries a boxed warning about bone mineral density loss. It advises against use longer than two years unless other methods are inadequate. This needs an individual discussion of bone health, other risks, and alternatives, rather than a self-directed stop that leaves a gap in protection.
Hormonal and Copper IUDs
Hormonal IUDs release a progestin primarily within the uterus, with some systemic absorption. Duration varies by device. Both Mirena and Liletta are labeled for contraception for up to eight years and heavy menstrual bleeding for up to five years in people choosing intrauterine contraception. Do not apply those durations to every hormonal IUD.
Many people find their periods get much lighter, and some stop having periods at all.
That last part can make it harder to tell when you have reached menopause, since there is no bleeding pattern to watch.
Different use, different timeline: Using a levonorgestrel intrauterine system for endometrial protection alongside systemic estrogen is off-label in the United States. Ask which device and replacement interval are appropriate. An eight-year contraceptive duration does not establish eight years of endometrial protection during estrogen therapy.
Ask your clinician before you assume your IUD covers the progestin part of hormone therapy.
The copper IUD contains no hormones. Paragard is labeled for pregnancy prevention for up to 10 years. Confirm the exact device rather than assuming all products have identical labeling.
Periods may get heavier and crampier, which can be a real problem if your bleeding is already hard to forecast.
Barrier and Permanent Methods
Condoms (external and internal), the diaphragm, the cervical cap, the sponge, and spermicide all work without hormones and get used as needed. How well they work depends heavily on using them correctly every time.
Tubal procedures and a partner’s vasectomy are meant to be permanent. They leave your hormones alone.
Ask about procedure risks and alternatives, including long-acting reversible methods. Do not choose a permanent method on the assumption that it can reliably be reversed. Vasectomy is not immediately reliable; continue the advised backup method until semen testing confirms success.
Comparison Table
The figures below are approximate pregnancies per 100 users during the first year of typical use, including real-world missed or incorrect use. Lower numbers indicate fewer pregnancies. These are general population estimates, not individualized predictions for women in perimenopause; they do not measure symptom relief.
| Method | Pregnancies per 100 users: typical use | Hormones | Possible bleeding effect | Practical considerations |
|---|---|---|---|---|
| Combined pill | 7 | Estrogen + progestin | Often more predictable | Daily task; estrogen eligibility matters |
| Patch | 7 | Estrogen + progestin | Often more predictable | Usually weekly changes; product-specific restrictions |
| Contraceptive ring | 7 | Estrogen + progestin | Often more predictable | Follow the specific ring’s use and replacement schedule |
| Progestin-only pill | 7 | Progestin | Irregular bleeding or spotting | Daily task; timing windows differ by formulation |
| DMPA injection | 4 | Progestin | Initially irregular; periods may stop | Repeat injections; bone-health discussion |
| Implant | 0.1 | Progestin | Often unpredictable | Clinician placement and removal; Nexplanon up to five years |
| Hormonal IUD | 0.1–0.4 | Progestin | Often lighter; periods may stop | Device- and indication-specific replacement date |
| Copper IUD | 0.8 | None | May be heavier or more painful | Clinician placement; exact device matters |
| External condom | 13 | None | No direct hormonal effect | Use each time; suitable materials reduce STI risk |
| Internal condom | 21 | None | No direct hormonal effect | Use each time; STI-protection data are more limited |
| Tubal surgery | 0.5 | None | No direct hormonal effect | Intended to be permanent; procedure risks |
| Partner vasectomy | 0.15 | None | No direct effect on partner’s cycle | Intended to be permanent; testing must confirm success |
Sources: CDC contraceptive effectiveness estimates and CDC permanent contraception guidance. Typical use differs from perfect use, which assumes consistent correct use. This table uses one measure throughout rather than mixing the two. For duration, use current product labels: the CDC overview’s older three-year implant description does not reflect the January 2026 Nexplanon update. Information checked November 3, 2026.
How Medical History, Smoking, Migraine, Blood Pressure, and Medications Affect Eligibility
Clinicians use the CDC U.S. Medical Eligibility Criteria to assess suitability across health conditions and methods. A category for one method does not automatically apply to another.
A few factors come up again and again in midlife.
Smoking. At 35 or older, combined hormonal methods are generally advised against, and the CDC rates the risk higher for heavier smoking. Progestin-only methods, IUDs, and non-hormonal options get weighed differently.
Mention vaping and other nicotine use as well; do not assume that cigarette-based classifications establish equivalent safety for vaping.
Migraine with aura. Estrogen-containing methods are generally avoided because of stroke risk. Tell your clinician what kind of headaches you get, because “bad headaches” and “migraine with aura” mean different things.
Describe all visual, sensory, or speech symptoms and whether they occur with or without headache; let a clinician determine whether they represent aura. New or sudden neurologic symptoms need urgent assessment.
Blood pressure. How high it runs and how well it is controlled both matter. Estrogen can be a problem in some cases.
Clots, cancer history, liver disease, and unexplained bleeding. These need method-specific assessment. For example, current breast cancer can make hormonal methods unsuitable; an estrogen-free method is not automatically appropriate. Unexplained bleeding may need investigation before selecting a method.
Medications. Some seizure medicines, rifampin, certain HIV medicines, and St. John’s wort can affect particular hormonal methods. Interactions vary by product; a pharmacist or clinician should check your complete list rather than assuming all methods are affected equally.
Bring a full list that includes supplements.
Weight, diabetes, cholesterol, and bone health. Mention all of them. Your numbers and history decide this, and age alone does not.
Birth Control Versus Menopausal Hormone Therapy
Menopausal hormone therapy is not contraception.
Depending on the product, menopausal hormone therapy addresses symptoms such as hot flashes or vaginal dryness. Contraception and menopausal therapy have different formulations, purposes, and risks; comparing hormone amounts across products can be misleading.
If you can still get pregnant while taking it, you need a separate contraceptive method.
A clinician may consider a suitable contraceptive that also addresses a symptom-management goal. Whether the symptom use is approved or off-label depends on the exact product and condition. Do not add menopausal hormones to a contraceptive regimen without clinical advice.
When the time comes to stop contraception and think about hormone therapy, clinicians usually plan the handoff on purpose and do not leave it to chance.
For the full comparison, read our hormone therapy article. If you want the wider picture of symptom care, the treatment overview lays out the categories side by side.
Switching Methods, Assessing Menopause, and Planning When to Stop
Switching methods is common. Your clinician can tell you whether you need backup protection during the changeover and for how long.
Figuring out whether you have reached menopause gets harder when your method hides the signs. Pills and hormonal IUDs can mask the bleeding pattern.
CDC notes that no reliable laboratory test confirms definitive loss of fertility. FSH measurements can be misleading, particularly when hormonal treatment affects interpretation.
CDC summarizes professional recommendations to continue contraception until menopause or approximately age 50–55, while weighing the risks of both pregnancy and continued method use. This is not an instruction to continue every method until 55 or to stop automatically at 50.
Ask how your age, method, bleeding pattern, and history affect the stopping or switching plan. Do not stop a hormonal method simply to obtain a blood test or interpret a missed period.
If protection may have lapsed or a condom broke, emergency contraception may be relevant. Contact a pharmacist or clinician promptly because options are time-sensitive and can affect when a hormonal method is started or resumed.
Bleeding Changes and Warning Signs Needing Assessment
Irregular bleeding is common in perimenopause. Some changes call for prompt evaluation:
- Soaking through a pad or tampon every hour for several hours
- Bleeding after menopause, or new bleeding after a prolonged gap that your clinician did not identify as an expected method effect
- New or persistent bleeding between periods
- Bleeding after sex
- Periods much heavier or longer than your usual
- Pelvic pain, fever, or unusual discharge, especially with an IUD
Call 911 for sudden chest pain, shortness of breath, stroke symptoms such as weakness or trouble speaking, or a sudden severe headache. These symptoms need emergency assessment whether or not you use estrogen. New pain or swelling in one leg needs urgent medical assessment.
Heavy bleeding with fainting, marked dizziness, chest pain, or shortness of breath needs emergency care. ACOG describes emergency signs of abnormal uterine bleeding. Do not wait to reach a pad-count or time threshold if seriously unwell.
Severe pelvic pain, fainting, or a positive pregnancy test with an IUD also needs prompt assessment, including consideration of ectopic pregnancy. Do not try to remove an IUD yourself.
STI Protection Is Separate
Most contraceptive methods do not protect against STIs. Correct, consistent use of suitable external condoms reduces risk; natural-membrane or lambskin condoms should not be relied on for STI protection. Internal condoms may offer protection, but evidence is more limited. Neither guarantees protection against every infection.
Midlife women face STI risk too, especially with a new partner. Ask your clinician about testing, and ask about using condoms on top of another method.
Appointment Checklist and FAQs
A little prep makes the visit go much further. Choosing the right birth control for perimenopause goes better when your clinician sees the full picture.
What to Bring
- Whatever bleeding and symptom notes you have (an app or paper calendar is fine); do not delay care to complete months of tracking
- Blood pressure readings, if you have them
- Your smoking and vaping status
- Details about any migraines, including aura
- A list of all medications and supplements
- Personal and family history of clots, stroke, breast cancer, and heart disease
- What you want most: lighter periods, no hormones, no daily task, or symptom relief
- Whether you might want a pregnancy in the future
What to Ask
Ask which methods fit your health history and which ones to skip. Ask what each one would do to your bleeding.
Ask how the two of you would know when you have reached menopause.
Ask whether any part of the plan is off-label, and what the evidence looks like. Ask whether you need backup protection and for how long.
Finally, ask when to revisit the plan.
Save this page or print the lists and take them with you. Doctors’ visits go fast, and a written list keeps the important stuff from slipping out of your head.
FAQs
Irregular periods and pregnancy. Pregnancy is still possible. Irregular periods do not rule out ovulation.
Hot flashes and fertility. Hot flashes can show up while ovulation is still happening, so they say little about whether you can get pregnant.
Hormone therapy and pregnancy prevention. Hormone therapy is not a contraceptive. A separate method is needed if pregnancy is still possible.
Hormonal IUDs and periods. A hormonal IUD can stop periods for some people, which may make menopause harder to spot.
IUDs and endometrial protection. Some clinicians use a hormonal IUD to protect the uterine lining during estrogen therapy. This is generally off-label in the U.S., so talk it over with your clinician.
Permanent contraception. It suits some people. It is a personal decision worth talking through carefully.
Contraception after 50. Age, method, medical history, and whether bleeding is masked all affect the plan. Twelve months without bleeding while using a method that suppresses periods does not by itself confirm menopause. Ask for an individual stopping or switching plan.
Sources and Further Reading
- CDC: Contraception and birth control methods
- CDC: U.S. Medical Eligibility Criteria
- CDC: U.S. Selected Practice Recommendations
- CDC: When contraceptive protection is no longer needed
- CDC: Permanent contraception
- ACOG journal clinical perspective: Hormonal options for perimenopause
- The Menopause Society: Perimenopause
- Nexplanon prescribing information
- Mirena prescribing information
- Liletta prescribing information
- Paragard prescribing information
- Depo-Provera CI prescribing information
Treatment and contraceptive decisions depend on your personal history and a discussion with a qualified healthcare professional.